Product Information
EPANED 1 MG/ML ORAL SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $4.4785 per ML under NDC 52652400101. Its NADAC has been published 488 times since Apr 19, 2017.
FDA first approved this application on Sep 20, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the enalapril maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/mL
Manufacturer
Azurity Pharmaceuticals Inc.NDC
52652400101
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ENALAPRIL MALEATEApproval Type
New Drug (NDA)
FDA Application
NDA208686FDA Approved
9/20/2016
TE Code
AB
On Market Since
10/3/2016
Pharmacological Classes
Price Statistics
The NADAC for EPANED 1 MG/ML ORAL SOLUTION has been published 488 times since Apr 19, 2017, and over the history we have for it it has risen 42.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4785 per ML |
|---|---|
| All-time high | $4.4791 (Aug 12, 2026) |
| All-time low | $3.1305 (Feb 21, 2018) |
| 52-week high | $4.4791 |
| 52-week low | $4.3227 |
| Median price | $3.4336 |
| Average price | $3.6066 |
| Largest weekly change | +9.9% (Jan 4, 2023) |
| Weeks tracked | 488 |
| Tracking since | Apr 19, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the enalapril maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EPANED 1 MG/ML ORAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for EPANED 1 MG/ML ORAL SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $4.4785 per ML (NDC 52652400101), effective Aug 19, 2026.
How has the price of EPANED 1 MG/ML ORAL SOLUTION changed over time?
Over the history we have for it, the NADAC for EPANED 1 MG/ML ORAL SOLUTION has risen 42.8%. It has been tracked across 488 weekly CMS publications since Apr 19, 2017.
What are the highest and lowest recorded NADAC prices for EPANED 1 MG/ML ORAL SOLUTION?
Since Apr 19, 2017, the NADAC for EPANED 1 MG/ML ORAL SOLUTION has ranged from a low of $3.1305 (Feb 21, 2018) to a high of $4.4791 (Aug 12, 2026), with a median of $3.4336 per ML.
Are there cheaper alternatives to EPANED 1 MG/ML ORAL SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of EPANED 1 MG/ML ORAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EPANED 1 MG/ML ORAL SOLUTION?
EPANED 1 MG/ML ORAL SOLUTION (NDC 52652400101) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.